399: Trust Strategies, Congress Gets Back to Work

Dr. LaQuandra Nesbitt, Senior Associate Dean at the George Washington University School of Medicine and Health, reflects on restoring trust in public health; Jeffrey Ekoma, ASTHO Senior Director of Government Affairs, tells us what to expect when Congress is back in session; ASTHO issues a statement supporting the Biden Administration's designation of Fentanyl and Xylazine as an emerging threat to the U.S.; online registration is open for ASTHO's Health Equity Summit; and registration for ASTHO's TechXpo and Futures Forum is still open for in person and online. Restoring Trust In Our Nation's Public Health System ASTHO Statement on Biden Administration Designating Fentanyl Combined with Xylazine as an Emerging Threat to the United States Overdose Data to Action Recipient Health Equity Needs Assessment Overview Health Equity Summit: A Movement for Justice Public Health TechXpo and Futures Forum